Origent Data Sciences utilizes Artificial Intelligence and Machine Learning to develop predictive analytics for drug rescue. Experts in ALS and other neurological diseases, Origent helps biotechs and pharmaceutical companies bring new therapies to market by reducing the time, cost, and risk of their clinical trials. Origent’s AI can also re-examine past failed clinical trials to determine whether the drug actually had a positive treatment effect that could be demonstrated in a new trial and hopefully result in the registration of the now rescued drug.